Albert Labs team
Dr. Michael Raymont
Dr. Raymont’s career has spanned leadership roles in venture capital, agricultural and healthcare investment, tech company leadership and senior Government service, where he ran the National Research Council (NRC), Canada’s largest R&D organization. With a background in both science and business, Dr. Raymont has advised corporations and governments, worked extensively internationally, and has sat on the boards of over 50 public and private companies.
Public Company Management and Accounting Professional including Financial, Disclosure and Compliance Responsibilities in the medical cannabis, agriculture, biotech, nutraceuticals, real estate development and business software systems industries with 20+ years of experience. Past experience includes Director and CEO of Grand Peak Capital Corp., a publicly listed Venture Capital Corp investing in portfolio of Resource and Technology Companies. Comprehensive understanding of the new technology and IP development with close relationships federal and provincial government funding agencies.
Chief Medical Officer
Dr Malcolm Barratt-Johnson
Malcolm has over 22 years in the pharmaceutical industry specialising in Medical Affairs, Product Development and Regulatory Strategy. Malcolm has worked extensively in senior positions to both Industry and Government. Holding positions at AstraZeneca, Roche, and the UK Medicines Regulatory Agency (MHRA) and European Medicines Evaluation Agency (EMEA). Most recently Malcolm acted as a Clinical Specialist and Chair to the European Commission’s Biomedical Research Programme (Horizon 2020), and has lectured in both Europe and the United States on medicinal development, and continues lecturing at King’s College and Imperial College, London.
Chief Commercial Officer
30+ years in the pharmaceutical industry holding senior management positions in Astra Zeneca, GlaxoSmithKline and Bristol Myers before starting two B2B companies specializing in Pharma Market Access, having brought in excess of 60 products to market in key areas of mental, cancer, and other national agenda diseases. A keen entrepreneur, Graeme enjoys growing start-up companies and has a special interest in new technologies that advance the improvement of healthcare delivery, unmet need and patient centred solutions.
Chief Development Officer
Ali has 15+ years engineering experience in the development and commercialization of novel process technologies in oil and gas, pulp and paper, electrochemistry and pharmaceutical sectors. In 2011, Ali founded AGEIAS Engineered Systems Ltd., an EPCM focused on the design and build of modular systems for proof of concept, demonstration, and commercial prototypes servicing clients from academic institutions, contract research organizations and laboratories. Ali has extensive experience in the management of both short term and longer multi-year R&D programs programs with a track record of commercialization.
Chief Communications Officer
Barney is a product & marketing entrepreneur in residence with the Conscious Fund. One of the most active venture funds in psychedelic medicine. Barney is also one of the founders of the Psychedelic Medicine Association where he serves as Chief Technical Officer. The Psychedelic Medicine Association is aimed at bridging the gap between the advances taking place in the psychedelic research world and medical practitioners. Prior to his work in the psychedelic industry Barney founded Noid Drinks a cannabinoid beverage company from the UK. Barney also holds a Masters degree in Engineering.
BA(Hons), MSc, D.ClinPsy, Cpsychol/Impact
Dr. Sara Tai
Dr Sara Tai is a Senior Lecturer in Clinical Psychology at the University of Manchester and Consultant Clinical Psychologist at Cheadle Royal Hospital and Greater Manchester West Mental Health NHS Foundation Trust. Sara is an experienced practitioner, trainer, and supervisor of transdiagnostic approaches for working with people with serious mental health problems and their families; providing one-to-one interventions, group interventions, and family work. She has an international reputation as a trainer in CBT and has published widely in this area, including the book “A principles-based approach to counselling and psychotherapy”.
DClinPsy, PhD, MA, HCPC
Dr. Sara Tookey
Dr. Tookey is a Clinical Psychologist, HCPC registered and BPS Chartered Psychologist. She holds a PhD in Psychology with a specialism in Psycho-oncology, a doctorate in Clinical Psychology and an MA in Existential Phenomenological Psychology. She is an experienced qualitative researcher and Qualitative Methods Lecturer. Sara specialises in integrative therapies, incorporating approaches of Cognitive Behavioral Therapy (CBT), Existential Therapy, Systemic, psycho-dynamically informed, Acceptance and Commitment Therapy (ACT), Compassion-focused therapy (CFT).
BSc Pharmacology, PhD in Psychopharmacology.
Professor Jo Neill
Jo is a Professor of Psychopharmacology at the University of Manchester. She is Chair of the Medical Psychedelics Working Group for Drug Science, a scientific advisor for Heroic Hearts UK, the Conservative Drug Policy Reform Group, Psychedelic Experience and Beckley Psytech. She is co-founder of b-neuro, a University-based Contract Research Organisation (CRO) developing new treatments for mental illness through animal models. Jo is past President of the British Association for Psychopharmacology.
BA Mod Hons, PhD
Professor Saoirse O’Sullivan
Saoirse is a Professor of Pharmacology in the Faculty of Medicine & Health Sciences at the University of Nottingham. Dr. O’Sullivan is a leading researcher in the field of cannabinoids and has published numerous papers on the role of cannabinoid receptors in health and disease. Dr. O’Sullivan brings cross-domain expertise surrounding the Pharmacology of natural medicines.
Dr Jonathan Curry
Dr Curry holds a PhD in Environmental Toxicology and is highly knowledgeable in a range of laboratory techniques including microbial cultivation and screening, chemical analysis, method validation, safety testing, regulatory compliance, and study design. With a strong foundation in mycology, he is experienced in maintaining microbial culture collections and optimizing growth parameters while preventing cross-contamination. Dr Curry currently works as a scientific consultant on global projects which require his knowledge of the behaviour of chemicals within complex biological systems, including commercial mushroom producers and biotechnology companies around the world.
FRCP, FRCPGlas, FFPMRCoA
Professor Emeritus Sam Ahmedzai
Professor Sam Ahmedzai is the National Institute for Health Research (NIHR) National Specialty Lead for Cancer: Supportive Care and Community-Based Research. He was a professor of supportive and palliative care at the University of Sheffield for 20 years and also served as a clinical expert adviser for NICE NHS Evidence; as a member of the council of the British Pain Society.
Professor Robert Britton
Professor Robert Britton obtained his B. Sc. from the University of Waterloo in 1996 working with Professor Victor Snieckus. He then earned a Ph. D. in natural product isolation, structural elucidation and total synthesis from the University of British Columbia in 2002 with Professors Edward Piers and Raymond Anderson. He spent two years at the University of Cambridge with Professor Ian Paterson as an NSERC PDF then joined the Process Research Group at Merck as a Senior Scientist in 2004. In 2005, he started an independent academic career at Simon Fraser University and was promoted to Professor in 2015. Professor Britton has broad research interests that include natural product drug discovery, medicinal chemistry, radiotracer development and insect communication. Research in these areas have led to commercial traps for bed bugs and other crop pests, 18F-labelled amino acids and peptides for PET imaging in oncology, new tools for late-stage modification of drug leads, new processes for improving the manufacture of drugs, and new strategies for synthesizing structurally complex natural products.
MBChB, BSc Psych
Dr. Lauren MacDonald
Dr Lauren Macdonald has a background in Psychology, Psychiatry and Integrative Medicine and works to support health, healing and optimal wellbeing. She advocates for incorporating nature into mainstream medicine, including the use of medical cannabis and psychedelic-assisted psychotherapy. In addition to working as a medical doctor, Dr Lauren Macdonald is a podcast host, writer and speaker. She also facilitates healing and transformative retreats that awaken the inner healer and allow a deeper connection with self, with others and the natural world.
Standing on the shoulders of the giants that went before.
We are driven to develop the vision of those that revealed the true power of psychedelics as medicines.
Let us tell you more.
We will email you to start the conversation.